Stock listing

EPRX Stock Price, News, Filings & Events — Eupraxia Pharmaceuticals, Inc.

Selected listing: EPRX · TSX · CAD · CA

EPRX:TSX is the primary listing for Eupraxia Pharmaceuticals, Inc., a public company with a market capitalization of approximately CAD 403.56 million. Eupraxia is dedicated to developing innovative pharmaceutical solutions aimed at addressing unmet medical needs. The company is actively involved in advancing its research and product pipeline, contributing to the evolving landscape of healthcare. Recent news and filings may provide insights into its ongoing projects and market positioning.

EPRX:TSXCADCAUpdated July 21, 2026
Eupraxia Pharmaceuticals, Inc. logo
Ticker
EPRX:TSX
Asset type
Stock
Market cap
$403.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
TSX
Currency
CAD

Eupraxia Pharmaceuticals, Inc. EPRX:TSX stock context

EPRX:TSX is the primary listing for Eupraxia Pharmaceuticals, Inc., a public company with a market capitalization of approximately CAD 403.56 million. Eupraxia is dedicated to developing innovative pharmaceutical solutions aimed at addressing unmet medical needs. The company is actively involved in advancing its research and product pipeline, contributing to the evolving landscape of healthcare. Recent news and filings may provide insights into its ongoing projects and market positioning.

Research Eupraxia Pharmaceuticals, Inc.

Alternate listings